Annual CFI
$15.81 M
+$132.24 M+113.58%
December 31, 2023
Summary
- As of March 12, 2025, BVS annual cash flow from investing activities is $15.81 million, with the most recent change of +$132.24 million (+113.58%) on December 31, 2023.
- During the last 3 years, BVS annual CFI has risen by +$36.31 million (+177.11%).
- BVS annual CFI is now at all-time high.
Performance
BVS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$64.00 K
+$13.00 K+16.88%
September 28, 2024
Summary
- As of March 12, 2025, BVS quarterly cash flow from investing activities is -$64.00 thousand, with the most recent change of +$13.00 thousand (+16.88%) on September 28, 2024.
- Over the past year, BVS quarterly CFI has increased by +$527.00 thousand (+89.17%).
- BVS quarterly CFI is now -100.19% below its all-time high of $33.50 million, reached on June 1, 2023.
Performance
BVS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$1.73 M
+$1.97 M+53.24%
September 28, 2024
Summary
- As of March 12, 2025, BVS TTM cash flow from investing activities is -$1.73 million, with the most recent change of +$1.97 million (+53.24%) on September 28, 2024.
- Over the past year, BVS TTM CFI has dropped by -$17.54 million (-110.96%).
- BVS TTM CFI is now -105.80% below its all-time high of $29.87 million, reached on March 30, 2024.
Performance
BVS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BVS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +113.6% | +89.2% | -111.0% |
| 3 y3 years | +177.1% | +100.0% | +99.4% |
| 5 y5 years | +359.1% | +100.0% | +99.4% |
BVS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +105.6% | -100.2% | +99.9% | -105.8% | +99.5% |
| 5 y | 5-year | at high | +105.6% | -100.2% | +100.0% | -105.8% | +99.5% |
| alltime | all time | at high | +105.6% | -100.2% | +100.0% | -105.8% | +99.5% |
Bioventus Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$64.00 K(-16.9%) | -$1.73 M(-53.2%) |
| Jun 2024 | - | -$77.00 K(-92.3%) | -$3.70 M(-112.4%) |
| Mar 2024 | - | -$1.00 M(+69.2%) | $29.87 M(+89.0%) |
| Dec 2023 | $15.81 M(-113.6%) | -$591.00 K(-71.0%) | $15.81 M(+21.6%) |
| Sep 2023 | - | -$2.04 M(-106.1%) | $12.99 M(-131.5%) |
| Jun 2023 | - | $33.50 M(-322.4%) | -$41.30 M(-67.4%) |
| Mar 2023 | - | -$15.07 M(+342.7%) | -$126.83 M(+8.9%) |
| Dec 2022 | -$116.44 M(-59.0%) | -$3.40 M(-94.0%) | -$116.44 M(-65.2%) |
| Sep 2022 | - | -$56.33 M(+8.3%) | -$334.31 M(+14.8%) |
| Jun 2022 | - | -$52.02 M(+1013.1%) | -$291.16 M(+20.4%) |
| Mar 2022 | - | -$4.67 M(-97.9%) | -$241.79 M(-14.8%) |
| Dec 2021 | -$283.76 M | -$221.28 M(+1578.1%) | -$283.76 M(+342.0%) |
| Sep 2021 | - | -$13.19 M(+398.0%) | -$64.19 M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$2.65 M(-94.3%) | -$68.77 M(+3.1%) |
| Mar 2021 | - | -$46.65 M(+2626.4%) | -$66.70 M(+225.4%) |
| Dec 2020 | -$20.50 M(+159.1%) | -$1.71 M(-90.4%) | -$20.50 M(+9.1%) |
| Sep 2020 | - | -$17.76 M(+2967.2%) | -$18.79 M(+1724.2%) |
| Jun 2020 | - | -$579.00 K(+28.4%) | -$1.03 M(+128.4%) |
| Mar 2020 | - | -$451.00 K(-93.2%) | -$451.00 K(-93.2%) |
| Dec 2019 | -$7.91 M(+29.7%) | - | - |
| Dec 2018 | -$6.10 M(-89.9%) | - | - |
| Mar 2016 | - | -$6.64 M(+2069.3%) | -$6.64 M(+2069.3%) |
| Dec 2015 | -$60.19 M(+91.8%) | - | - |
| Mar 2015 | - | -$306.00 K | -$306.00 K |
| Dec 2014 | -$31.38 M(+185.3%) | - | - |
| Dec 2013 | -$11.00 M | - | - |
FAQ
- What is Bioventus annual cash flow from investing activities?
- What is the all time high annual CFI for Bioventus?
- What is Bioventus annual CFI year-on-year change?
- What is Bioventus quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bioventus?
- What is Bioventus quarterly CFI year-on-year change?
- What is Bioventus TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bioventus?
- What is Bioventus TTM CFI year-on-year change?
What is Bioventus annual cash flow from investing activities?
The current annual CFI of BVS is $15.81 M
What is the all time high annual CFI for Bioventus?
Bioventus all-time high annual cash flow from investing activities is $15.81 M
What is Bioventus annual CFI year-on-year change?
Over the past year, BVS annual cash flow from investing activities has changed by +$132.24 M (+113.58%)
What is Bioventus quarterly cash flow from investing activities?
The current quarterly CFI of BVS is -$64.00 K
What is the all time high quarterly CFI for Bioventus?
Bioventus all-time high quarterly cash flow from investing activities is $33.50 M
What is Bioventus quarterly CFI year-on-year change?
Over the past year, BVS quarterly cash flow from investing activities has changed by +$527.00 K (+89.17%)
What is Bioventus TTM cash flow from investing activities?
The current TTM CFI of BVS is -$1.73 M
What is the all time high TTM CFI for Bioventus?
Bioventus all-time high TTM cash flow from investing activities is $29.87 M
What is Bioventus TTM CFI year-on-year change?
Over the past year, BVS TTM cash flow from investing activities has changed by -$17.54 M (-110.96%)